Do We Need TNM for Tracheal Cancers? Analysis of a Large Retrospective Series of Tracheal Tumors

Autor: Aleksandra Piórek, Adam Płużański, Paweł Teterycz, Dariusz Mirosław Kowalski, Maciej Krzakowski
Rok vydání: 2022
Předmět:
Zdroj: Cancers; Volume 14; Issue 7; Pages: 1665
ISSN: 2072-6694
Popis: Due to the low incidence of primary tracheal neoplasms, there is no uniform system for staging of this disease. Our retrospective analysis based on registry data included 89 patients diagnosed with primary tracheal cancer at the National Research Institute of Oncology in Warsaw, Poland, between January 2000 and December 2016. We analyzed demographic, clinical, pathological, therapeutic, and survival data. The staging—for the purpose of our analysis—was performed retrospectively on the basis of imaging results. Tumor (T) category was defined as a disease confined to the trachea or lesion derived from the trachea and spreading to adjacent structures and organs. Node (N) and metastases (M) categories were divided into absence/presence of metastasis in regional lymph nodes and the absence/presence of distant metastasis. Survival analysis was performed depending on the clinical presentation of these features. There was a significant difference in overall survival depending on the T, N, M categories in the entire group. In the group of patients undergoing radical treatment, the T and N categories had a statistically significant impact on overall survival. In the group of patients treated with palliative aim, only the T category had an impact on overall survival. Multivariate analysis showed statistical significance for the T category in patients undergoing radical and those receiving palliative treatment. The assessment of the anatomical extent of lesions may help decide about treatment options and prognosis.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje